WE-REACH

November 11, 2021

$14.9M Awarded to Lutz Lab’s COVID-19 Technology Company

Anavasi Diagnostics, a company recently founded out of Professor Barry Lutz’s lab at the University of Washington, announced it has been awarded $14.9 million from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADxSM) initiative. The funding will accelerate the launch and broad market availability of the AscencioDx™ molecular diagnostic platform for the detection of RNA indicative…


WE-REACH support helps team pivot from academia to small business venture

Flipping the switch from professor to entrepreneur — where one endures intense pace and high-pressure stakes— is a daunting proposition. Having access to a team of experts and services through Washington Entrepreneurial Research Evaluation & Commercialization Hub (WE-REACH), a group dedicated to transforming novel breakthroughs into innovative products, can make a huge difference. Take Dr….


August 6, 2021

WE-REACH Fall Proposal Due Date Extended to August 9th

WE-REACH’s Fall proposal submission deadline has been extended to August 9th! A 2-page Declaration of Intent is due by 5:00pm on August 9th for proof of product concept projects in the biotech space (medical devices, therapeutics, and diagnostics). Projects are funded between $75-185k. Full applications are due October 4th. Learn More!  


June 7, 2021

Immediate funding opportunity for point-of-care COVID variant testing and more! Deadline June 28

COVID-19 Funding Opportunity RADx Tech II: Fast-Track Program to Advance U.S. COVID-19 Testing Capabilities  The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is announcing today that its Point-of-Care Technology Research Network (POCTRN) is soliciting proposals to further advance SARS-CoV-2 testing technologies in order to fill specific unmet national needs. Unmet needs include but are not…


May 20, 2021

NIAID Applicant Assistance Program (AAP) Cycle Three Informational Webinar

NIAID Applicant Assistance Program (AAP) Cycle Three Informational Webinar Register for the NIAID Applicant Assistance Program (AAP) Cycle Three Informational Webinar on Tuesday May 25, 2021 at 2:00 p.m. EDT. This webinar will provide an introduction for the NIAID SBIR/STTR AAP program and the eligibility criteria. You will also have an opportunity to learn about…


May 18, 2021

WE-REACH Invests in Three Biomedical Innovations for Treatment Of Skin, Sepsis, & Kidney

WE-REACH

Seattle, WA (May 18, 2021)—The Washington Entrepreneurial Research Evaluation and Commercialization Hub (WE-REACH) is pleased to announce investments in three new awards to expedite early-stage product development for promising biomedical innovations. The three awards are intended to reduce skin injury from wound dressing, to treat COVID-19 induced viral sepsis, and to treat kidney disease. We…


March 30, 2021

RADx-UP Research Opportunity

A Notice of Intent to Publish has just been released for another RADx-UP ROA on Return to School: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-097.html To solicit research on COVID-19 diagnostic testing approaches to safely return children and staff to the in-person school setting in underserved and vulnerable communities.


NHLBI & ACC Innovation Showcase

The NHLBI Innovation Office is partnering with the American College of Cardiology (ACC) to put on an innovation showcase on April 1, 2021 from 4:00 – 7:00 pm PDT (7:00 – 10:00 pm EDT).  It will feature a panel of NHLBI experts, a presentation of NHLBI innovation services, and presentations/Q&A with 6 NHLBI SBIR Phase II…


March 11, 2021

Women’s Entrepreneurship Symposium 3/17

Women's Entrepreneurship Symposium

Next Wednesday: Resources for protecting your intellectual property   Don’t miss the next free, online installment of the 2021 annual Women’s Entrepreneurship Symposium (WES), “Resources for protecting your intellectual property,” coming Wednesday, March 17, from noon to 1:30 p.m. ET. Take this opportunity to learn about programs, resources, and information that can help with the protection…


January 5, 2021

Three Biomedical Innovations Spanning Neonatal to Elderly Care Win WE-REACH Go-To-Market Awards

WE-REACH

Seattle, WA (January 5, 2021)—The Washington Entrepreneurial Research Evaluation and Commercialization Hub (WE-REACH) is pleased to announce three new awards to expedite early-stage product development for promising biomedical innovations. WE-REACH invests up to $200,000 for each project with added resources and support. Project funding is made possible by public-private partnerships including the NIH, University of…


Next page